Longevity Lab ReportBeta
← All supplements

Supplement

BPC-157

Famous in gyms, absent from human trials.

BPC-157 is a synthetic peptide fragment derived from a stomach protein. We grade BPC-157 D on evidence and D for worth-it at about $30-60 per month.

D

Evidence

D

Worth it

Typical cost: $30-60/month

What it does

BPC-157 is a synthetic peptide fragment derived from a stomach protein. It circulates in online biohacker communities as a healing compound for tendons, gut, and injuries. It is not approved for human use by any regulator, and there are no published human randomized trials. Products sold online are unregulated research chemicals.

What the research says

  • May accelerate tissue healing

    Evidence: weak. Animal studies only. No published human randomized trials exist.

DRAFT: no published human trials; the entire case rests on animal work and anecdote. Animal data does not transfer to humans.

Is it worth it?

D

DRAFT: you are paying research-chemical prices for unregulated products with no human efficacy data.

Typical cost

$30-60/month

Common form, not a brand recommendation

Dosage contextno established dose

No established human dosage exists. Animal doses do not translate to humans.

Safety notes

Not approved for human use. Human safety data does not exist. Online products are unregulated with unknown purity. Banned by WADA for athletes. Talk to your doctor; do not self-experiment. This page is information, not medical advice.

Longevity Lab Report

BPC-157 news, graded when it happens.

New studies, dose debates, and expert shifts on bpc-157, in one email a week. Free.

Changelog

Last updated 2026-10-15

  • 2026-10-15|Peptide/longevity entry added as DRAFT with research-compound framing where applicable.
  • 2026-10-15|Dosage context added.
  • 2026-10-15|Goal tags added for the stack builder.
  • 2026-10-15|Regulatory: Feb 2026 HHS announcement moved BPC-157 toward Category 1 (compounding-eligible with prescription); July 2026 FDA PCAC voted to recommend it for the 503A Bulks List (non-binding, over agency scientists' objection). Not FDA approval. Evidence grade unchanged. Source: https://www.ajmc.com/view/5-things-to-know-about-the-fda-s-peptide-reversal